Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alivus Life Sciences Ltd.
NSE: ALIVUS
|
BSE: 543322
|
ISIN: INE03Q201024
|
Industry: Pharmaceuticals
Rapid Results
|
Slowing Down Stock
965.7000
-34.90
(
-3.49
%)
NSE
Aug 04, 2025
15:31 PM
27.67% Fall from 52W High
Volume:
128.1K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alivus Life Sciences Ltd.
16 Jul 2024
Rapid Results
965.70
-3.49%
Glenmark Life Sciences Ltd
Buy:
Alivus Life Sciences Ltd.
by
Hem Securities
Target: 987
Hem Securities
Alivus Life Sciences.. has an
average target
of 1317.00 from 1 broker.
More from Alivus Life Sciences Ltd.
Recommended
Market closes higher, Marico's revenue grows 23.3% YoY to Rs 3,259 crore in Q1
Trendlyne Marketwatch |
04 Aug 2025, 03:58PM
IPO calendar fills up: 12 new issues, and 12 listings this week
|
04 Aug 2025, 03:44PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
|
27 Jul 2021